Hem › Icke-småcellig lungcancer › Vermont › Burlington
Kliniska studier för Icke-småcellig lungcancer i Burlington, VT
4 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Burlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
RekryterarFas 2
- University of Vermont Medical Center, Burlington
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekryterarFas 3
- The University of Vermont Medical Center Inc., Burlington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- The University of Vermont Medical Center Inc., Burlington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Burlington
- Hjärtsvikt8 studier
- Akut myeloid leukemi7 studier
- Cancer (alla typer)6 studier
- KOL5 studier
- Bröstcancer5 studier
- Leukemi4 studier
- Parkinsons sjukdom4 studier
- Lungcancer4 studier
- Hjärt-kärlsjukdom4 studier
- Cystisk fibros4 studier
- Prostatacancer4 studier
- Metastaserande cancer4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.